Skip to main content

Table 2 Significant linear regression coefficients of stages of change predicting SCL-90 symptomatology at the end of therapy

From: Increasing the treatment motivation of patients with somatic symptom disorder: applying the URICA-S scale

      

95% CI

 
 

B

SE B

β

t

p

Lower bound

Upper bound

R2

Model 1: Maintenance t1

.57

 Constant

.31

.15

 

2.11

.039

.02

.61

 

 SCL-90 baseline

.26

.08

.36

3.31

<.001

.10

.42

 

 Maintenance t1

.23

.08

.32

2.92

.005

.07

.38

 

Model 2: Maintenance t2

.53

 Constant

.36

.16

 

2.27

.027

.04

.69

 

 SCL-90 baseline

.25

.07

.42

3.50

<.001

.11

.39

 

 Maintenance t2

.15

.08

.23

1.89

.065

−.01

.31

 

Model 3: Maintenance t3

.70

 Constant

−.18

.13

 

−1.33

.191

−.45

.09

 

 SCL-90 baseline

.84

.09

.77

9.14

<.001

.66

1.03

 

 Maintenance t3

.10

.05

.16

1.90

.069

−.01

.21

 
  1. t1/t2/t3 = at baseline/after 8th therapy session/ end of therapy. Model 1 / Model 2 / Model 3 = significant stages of change predictors at baseline/8th/last therapy session for SCL-90 at the end of therapy.
  2. SCL-90-R Symptom-Checklist-90-Revised